Physician profile
Baruch Grob
NPI 1760427595
$2,291.19
in general payments reported to CMS, 2019-2025
11 companies · $389 in 2025
The $389 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.33 · 2021: $102 · 2022: $260 · 2023: $998 · 2024: $500 · 2025: $389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,572 · Travel and Lodging: $315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,571.56 |
| Travel and Lodging | $314.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $555.84 | 2023 | Prolaris |
| Pfizer INC. | $477.76 | 2024 | |
| Boston Scientific Corporation | $333.81 | 2022-2025 | General - Erectile Dysfunction, Bulkamid, Ams 700 |
| Karl Storz Endoscopy-America | $225.21 | 2023-2025 | N.A., Flex-X |
| Dendreon Pharmaceuticals LLC | $149.86 | 2023 | Provenge |
| Coloplast Corp | $119.62 | 2021-2022 | |
| Olympus America INC. | $110.80 | 2023 | Itind System |
| Axonics, INC. | $105.46 | 2022 | |
| Photocure INC | $95.03 | 2023 | Cysview |
| Urogen Pharma, INC. | $75.47 | 2025 | |
| Astellas Pharma US INC | $42.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Baruch Grob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.